Riskpilot← Back to searchSign inGet full accessTajeri & Co AB
ABActiveOrg 5591573802Skeppargatan 32 Lgh 1303Medical specialists activities · NACE 8622Est. 20180 employees
Revenue 2024
SEK 1,6M
+43% vs 2023
EBITDA margin
21.3%
+254% vs 2023
Equity ratio
6.6%
Financial strength
Net profit 2024
SEK 67K
+225% vs 2023
| Revenue | SEK 1,6M | +43% |
| EBITDA | SEK 332K | +254% |
| Net profit | SEK 67K | +225% |
| Total assets | SEK 2,1M | +16% |
| Equity | SEK 138K | -38% |
| Employees | 0 | — |
Legal name
Tajeri & Co AB
Org number
5591573802
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
27 april 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva verksamhet inom försäljning av läkartjänster, uthyrning av läkare, konsulttjänster riktade mot läkare från andra EU-länder som vill arbeta och etablera sig i Sverige samt skönhetsvård.
Address
Skeppargatan 32 Lgh 1303
Email
aydin_taj@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 557 | 1 212 | 1 236 | 1 096 | 1 562 |
| Staff expenses | — | — | −487 | −475 | −682 |
| EBITDA | 500 | 343 | 360 | 94 | 332 |
| Depreciation & amort. | −142 | −142 | −142 | −95 | — |
| EBIT | 358 | 201 | 218 | −1 | 332 |
| Net financials | −9 | 7 | −50 | −146 | −228 |
| Profit before tax | 252 | 208 | 168 | −49 | 104 |
| Tax | −64 | −55 | −44 | −5 | −37 |
| Net profit | 188 | 153 | 125 | −53 | 67 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 368 | 1 721 | 1 873 | 1 801 | 2 092 |
| Equity | 371 | 524 | 469 | 221 | 138 |
| Long-term debt | 412 | 380 | 959 | 1 335 | 1 580 |
| Short-term debt | 487 | 719 | 347 | 246 | 375 |
| Total debt | 899 | 1 099 | 1 306 | 1 581 | 1 954 |
EBITDA margin
21.3%
This company
15.8%
Market median
+35% vs market
20202024
Equity ratio
6.6%
This company
38.2%
Market median
-83% vs market
20202024
Return on equity
48.6%
This company
18.4%
Market median
+164% vs market
20202024
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
20202024
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20202024
Debt / equity
14.21×
This company
0.62×
Market median
-2192% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tajeri & Co AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aydin Tajeri | Board of Directors | 0 companies |
| Kimia Abravan | Deputy Board Member | 0 companies |
| Sharon Shaghayegh Hosseini | Board of Directors | 0 companies |